and second line imatinib treatment in chronic myelogenous leukemia
patients expressing rare e1a2 or e19a2 BCR-ABL transcripts.
A Worldwide Support Network For Chronic Myelogenous Leukemia
hematopoietic function and multiple bone marrow clonal abnormalities in
a patient with acute myeloid leukemia after two mismatched stem-cell
transplants with graft failure and autologous reconstitution.
Cell Genesys have started three new clinical The trials are now under way in
trials for GVAX immunotherapy for leukemia, following encouraging
results in a phase II study.
collaboration with the Johns Hopkins Sidney Kimmel Cancer Center in
patients with chronic myelogenous leukemia (CML). The studies include a
new phase II trial, an extension of the original phase II trial, and a
new phase I trial.
Cell Genesys have started three new clinical
The trials are now under way in